4-(苯基乙炔基)吡啶-3-甲腈 | 118159-97-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 4-(苯基乙炔基)吡啶-3-甲腈
• 英文名称: 3-cyano-4-(phenylethynyl)pyridine
• 英文别名: 4-(2-Phenylethynyl)pyridine-3-carbonitrile
• CAS: 118159-97-0
• 化学式: C₁₄H₈N₂
• 分子量: 204.231
• InChiKey: SUBZOFHHLUDNDB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  36.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(苯基乙炔基)吡啶-3-甲腈 在 硫酸 、 氨 作用下， 以 水 、 乙二醇甲醚 为溶剂， 反应 1.0h， 以40%的产率得到3-phenyl-2,7-naphthyridin-1(2H)-one
  参考文献：
  名称：

  [EN] TANKYRASE INHIBITORS
  [FR] INHIBITEURS DE TANKYRASE

  摘要：

  本发明涉及一种具有式I的化合物，其中X为C(R6)或N，Y为C或N，环A、环B、R1和R2具有本文中定义的含义，前提是当环B为碳环时，X为C(R6)；或其药学上可接受的盐或溶剂。这些化合物是坦克酶-1和坦克酶-2抑制剂，并可用于治疗多种疾病，包括癌症。

  公开号：

  WO2014087165A1
• 作为产物：
  描述：

  4-氯-3-氰基吡啶 、 苯乙炔 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 、 三乙胺 作用下， 反应 6.0h， 以74%的产率得到4-(苯基乙炔基)吡啶-3-甲腈
  参考文献：
  名称：

  Sakamoto, Takao; An-Naka, Masayuki; Kondo, Yoshinori, Chemical and pharmaceutical bulletin, 1988, vol. 36, # 5, p. 1890 - 1894

  摘要：

  DOI：

文献信息

• Palladium-Catalyzed Sonogashira Coupling of a Heterocyclic Phosphonium Salt with a Terminal Alkyne
  作者：Qing-Dong Wang、Si-Xuan Zhang、Zhuo-Wen Zhang、Ying Wang、Mengtao Ma、Xue-Qiang Chu、Zhi-Liang Shen

  DOI：10.1021/acs.orglett.2c01800

  日期：2022.7.15

  An efficient Sonogashira coupling of a heterocyclic phosphonium salt with a terminal alkyne via C–P bond cleavage was developed. The reactions proceeded smoothly in the presence of palladium catalyst, copper(I) iodide, and N,N-diisopropylethylamine (DIPEA) in N-methyl-2-pyrrolidone (NMP) at 100 °C for 12 h, producing the corresponding alkynyl-substituted pyridine, quinoline, pyrazine, and quinoxaline

  开发了一种通过 C-P 键断裂将杂环鏻盐与末端炔烃有效的 Sonogashira 偶联。反应在钯催化剂、碘化铜 (I) 和N- , N-二异丙基乙胺 (DIPEA) 的存在下在N-甲基-2-吡咯烷酮 (NMP) 中在 100 °C 下顺利进行 12 h，生成相应的炔基-取代吡啶、喹啉、吡嗪和喹喔啉，产率中等至良好，底物范围广，官能团耐受性广。此外，还可以实现克级合成，该反应可应用于糖类、药物和天然产物（如雌酮、d-吡喃半乳糖、薄荷醇和布洛芬）。
• Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases
  作者：Katerina Kumpan、Amit Nathubhai、Chenlu Zhang、Pauline J. Wood、Matthew D. Lloyd、Andrew S. Thompson、Teemu Haikarainen、Lari Lehtiö、Michael D. Threadgill

  DOI：10.1016/j.bmc.2015.05.005

  日期：2015.7

  The tankyrases are members of the PARP superfamily; they poly(ADP-ribosyl) ate their target proteins using NAD(+) as a source of electrophilic ADP-ribosyl units. The three principal protein substrates of the tankyrases (TRF1, NuMA and axin) are involved in replication of cancer cells; thus inhibitors of the tankyrases may have anticancer activity. Using structure-based drug design and by analogy with known 3-arylisoquinolin-1-one and 2-arylquinazolin-4-one inhibitors, series of arylnaphthyridinones, arylpyridinopyrimidinones and their tetrahydro-derivatives were synthesised and evaluated in vitro. 7-Aryl-1,6-naphthyridin-5-ones, 3-aryl-2,6-naphthyridin-1-ones and 3-aryl-2,7-naphthyridin-1-ones were prepared by acid-catalysed cyclisation of the corresponding arylethynylpyridinenitriles or reaction of bromopyridinecarboxylic acids with beta-diketones, followed by treatment with NH3. The 7-aryl-1,6-naphthyridin-5-ones were methylated at 1-N and reduced to 7-aryl-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-ones. Cu-catalysed reaction of benzamidines with bromopyridinecarboxylic acids furnished 2-arylpyrido[2,3-d]pyrimidin-4-ones. Condensation of benzamidines with methyl 1-benzyl-4-oxopiperidine-3-carboxylate and deprotection gave 2-aryl-5,6,7,8-tetrahydropyrido[4,3-d] pyrimidin-4-ones, aza analogues of the known inhibitor XAV939. Introduction of the ring-N in the arylnaphthyridinones and the arylpyridopyrimidinones caused > 1000-fold loss in activity, compared with their carbocyclic isoquinolinone and quinazolinone analogues. However, the 7-aryl-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-ones showed excellent inhibition of the tankyrases, with some examples having IC50 = 2 nM. One compound (7-(4-bromophenyl)-1-methyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-one) showed 70-fold selectivity for inhibition of tankyrase-2 versus tankyrase-1. The mode of binding was explored through crystal structures of inhibitors in complex with tankyrase-2. (C) 2015 Elsevier Ltd. All rights reserved.
• SAKAMOTO, TAKAO;AN-NAKA, MASAYUKI;KONDO, YOSHINORI;ARAKI, TOMIO;YAMANAKA,+, CHEM. AND PHARM. BULL., 36,(1988) N 5, 1890-1894
  作者：SAKAMOTO, TAKAO、AN-NAKA, MASAYUKI、KONDO, YOSHINORI、ARAKI, TOMIO、YAMANAKA,+

  DOI：——

  日期：——